ARCHIVES

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

This article is from The Cancer Letter archive.

Vol. 15 No. 42 | November 3, 1989

Download PDF Visit The Full Archive

Related Articles

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

Bushes Restate Commitment to Dialogue

August 8, 2003

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

AACI Developing Suggestions Or New Cancer Control Grant Guidelines

July 20, 1979

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Cancer Center To Get Recommended Funding, Restoration of 1990-91 Cuts, NCI Tells Directors

July 24, 1992